Nasdaq:US$13.29 (+0.10) | HKEX:HK$20.54 (+0.24) | AIM:£2.02 (+0.02)
搜索
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2010-10-16

ISSX 2011: Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013 (fruquintinib), a novel potent and specific VEGFR inhibitor